Toll Free: 1-888-928-9744

Asahi Kasei Pharma Corp. - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 53 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Asahi Kasei Pharma Corp. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Asahi Kasei Pharma Corp. - Product Pipeline Review - 2014', provides an overview of the Asahi Kasei Pharma Corp.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Asahi Kasei Pharma Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Asahi Kasei Pharma Corp. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Asahi Kasei Pharma Corp.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Asahi Kasei Pharma Corp.'s pipeline products

Reasons to buy

- Evaluate Asahi Kasei Pharma Corp.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Asahi Kasei Pharma Corp. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Asahi Kasei Pharma Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Asahi Kasei Pharma Corp. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Asahi Kasei Pharma Corp.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Asahi Kasei Pharma Corp. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Asahi Kasei Pharma Corp. Snapshot 5
Asahi Kasei Pharma Corp. Overview 5
Key Information 5
Key Facts 5
Asahi Kasei Pharma Corp. - Research and Development Overview 6
Key Therapeutic Areas 6
Asahi Kasei Pharma Corp. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Asahi Kasei Pharma Corp. - Pipeline Products Glance 13
Asahi Kasei Pharma Corp. - Late Stage Pipeline Products 13
Pre-Registration Products/Combination Treatment Modalities 13
Phase III Products/Combination Treatment Modalities 14
Asahi Kasei Pharma Corp. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Asahi Kasei Pharma Corp. - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Asahi Kasei Pharma Corp. - Drug Profiles 18
collagenase clostridium histolyticum 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
thrombomodulin alfa 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
zoledronic acid 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
AK-106 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
elcatonin 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
fasudil 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
pentosan polysulfate sodium 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
ATS-8535 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecules to Antagonize EP1 Receptor for Overactive Bladder 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecule for Rheumatoid Arthritis and Autoimmune Diseases 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecules to Inhibit ADAMTS-5 for Undisclosed Indication 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Asahi Kasei Pharma Corp. - Pipeline Analysis 34
Asahi Kasei Pharma Corp. - Pipeline Products by Target 34
Asahi Kasei Pharma Corp. - Pipeline Products by Route of Administration 36
Asahi Kasei Pharma Corp. - Pipeline Products by Molecule Type 37
Asahi Kasei Pharma Corp. - Pipeline Products by Mechanism of Action 38
Asahi Kasei Pharma Corp. - Recent Pipeline Updates 39
Asahi Kasei Pharma Corp. - Dormant Projects 49
Asahi Kasei Pharma Corp. - Discontinued Pipeline Products 50
Discontinued Pipeline Product Profiles 50
teriparatide acetate transdermal patch 50
Asahi Kasei Pharma Corp. - Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Appendix 52
Methodology 52
Coverage 52
Secondary Research 52
Primary Research 52
Expert Panel Validation 52
Contact Us 53
Disclaimer 53
List of Tables
Asahi Kasei Pharma Corp., Key Information 5
Asahi Kasei Pharma Corp., Key Facts 5
Asahi Kasei Pharma Corp. - Pipeline by Indication, 2014 8
Asahi Kasei Pharma Corp. - Pipeline by Stage of Development, 2014 9
Asahi Kasei Pharma Corp. - Monotherapy Products in Pipeline, 2014 10
Asahi Kasei Pharma Corp. - Partnered Products in Pipeline, 2014 11
Asahi Kasei Pharma Corp. - Partnered Products/ Combination Treatment Modalities, 2014 12
Asahi Kasei Pharma Corp. - Pre-Registration, 2014 13
Asahi Kasei Pharma Corp. - Phase III, 2014 14
Asahi Kasei Pharma Corp. - Phase II, 2014 15
Asahi Kasei Pharma Corp. - Preclinical, 2014 16
Asahi Kasei Pharma Corp. - Discovery, 2014 17
Asahi Kasei Pharma Corp. - Pipeline by Target, 2014 35
Asahi Kasei Pharma Corp. - Pipeline by Route of Administration, 2014 36
Asahi Kasei Pharma Corp. - Pipeline by Molecule Type, 2014 37
Asahi Kasei Pharma Corp. - Pipeline Products by Mechanism of Action, 2014 38
Asahi Kasei Pharma Corp. - Recent Pipeline Updates, 2014 39
Asahi Kasei Pharma Corp. - Dormant Developmental Projects,2014 49
Asahi Kasei Pharma Corp. - Discontinued Pipeline Products, 2014 50
Asahi Kasei Pharma Corp., Subsidiaries 51 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify